
Y-mAbs Therapeutics YMAB
Quartalsbericht 2025-Q2
hinzugefügt 08.08.2025
Y-mAbs Therapeutics P/E 2011-2026 | YMAB
P/E Jährlich Y-mAbs Therapeutics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -7.29 | -33.8 | -1.4 | -7.12 | -14.1 | -14.7 | -13.5 | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -1.4 | -33.8 | -13.1 |
P/E anderer Aktien in der Pharmaeinzelhändler
| Name | P/E | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-0.612 | - | 2.43 % | $ 254 M | ||
|
AbCellera Biologics
ABCL
|
-6.57 | $ 3.55 | -0.42 % | $ 1.06 B | ||
|
Acorda Therapeutics
ACOR
|
-0.0662 | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
-4.26 | - | 4.01 % | $ 150 M | ||
|
Advaxis
ADXS
|
-0.0388 | - | -9.65 % | $ 45.9 M | ||
|
AC Immune SA
ACIU
|
-4.18 | $ 3.24 | 3.35 % | $ 229 M | ||
|
I-Mab
IMAB
|
-0.236 | - | - | $ 866 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-3.48 | - | - | $ 1.01 B | ||
|
AgeX Therapeutics
AGE
|
-0.00095 | - | -10.17 % | $ 12.2 K | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
55.7 | - | - | $ 40.3 B | ||
|
Biophytis SA
BPTS
|
-17.6 | - | -13.47 % | $ 169 M | ||
|
Albireo Pharma
ALBO
|
-15.8 | - | -0.23 % | $ 916 M | ||
|
Aileron Therapeutics
ALRN
|
-0.608 | - | 10.36 % | $ 9.8 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.57 | - | -1.52 % | $ 24.7 M | ||
|
ADC Therapeutics SA
ADCT
|
-5.3 | $ 4.14 | -1.9 % | $ 105 M | ||
|
Midatech Pharma plc
MTP
|
-14.5 | - | -18.52 % | $ 27.3 M | ||
|
Aptorum Group Limited
APM
|
-0.958 | $ 0.82 | 4.22 % | $ 4.47 M | ||
|
argenx SE
ARGX
|
-33.7 | $ 714.55 | 1.6 % | $ 25 B | ||
|
Adverum Biotechnologies
ADVM
|
-0.583 | - | - | $ 86.2 M | ||
|
Ascendis Pharma A/S
ASND
|
-19.2 | $ 231.26 | 0.1 % | $ 5 B | ||
|
Alterity Therapeutics Limited
ATHE
|
-66.5 | $ 3.4 | -5.82 % | $ 8.18 B | ||
|
Atea Pharmaceuticals
AVIR
|
-2.69 | $ 6.09 | 0.66 % | $ 496 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-1.71 | - | - | $ 26.5 M | ||
|
Applied Molecular Transport
AMTI
|
-0.175 | - | - | $ 10.1 M | ||
|
Arcturus Therapeutics Holdings
ARCT
|
-3.3 | $ 6.6 | -0.45 % | $ 181 M | ||
|
Институт стволовых клеток человека
ISKJ
|
38.8 | - | - | - | ||
|
BioCardia
BCDA
|
-0.769 | $ 1.37 | 7.87 % | $ 29 M | ||
|
Akero Therapeutics
AKRO
|
-12.9 | - | - | $ 3.67 B | ||
|
Athersys
ATHX
|
-4.62 | - | 3.77 % | $ 22.4 M | ||
|
Akouos
AKUS
|
-1.98 | - | 0.23 % | $ 488 M | ||
|
Acer Therapeutics
ACER
|
-0.463 | - | 2.71 % | $ 14 M | ||
|
ARCA biopharma
ABIO
|
-5.78 | - | 1052.0 % | $ 415 M | ||
|
Allena Pharmaceuticals
ALNA
|
-2.17 | - | 3.16 % | $ 1.9 M | ||
|
Aeterna Zentaris
AEZS
|
-4.94 | - | 5.93 % | $ 314 M | ||
|
AlloVir
ALVR
|
-0.833 | - | 4.14 % | $ 49.1 M | ||
|
Catalyst Biosciences
CBIO
|
101 | $ 11.29 | -2.5 % | $ 1.01 B | ||
|
Anika Therapeutics
ANIK
|
-4.51 | $ 14.61 | 1.71 % | $ 214 M | ||
|
Aptinyx
APTX
|
-0.146 | - | -39.0 % | $ 4.57 M | ||
|
Aptose Biosciences
APTO
|
-0.0913 | - | -45.71 % | $ 1.2 M | ||
|
AVEO Pharmaceuticals
AVEO
|
-1.84 | - | - | $ 521 M | ||
|
Ayala Pharmaceuticals
AYLA
|
-0.203 | - | - | $ 7.46 M | ||
|
BioNTech SE
BNTX
|
6.11 | $ 92.9 | 2.61 % | $ 27.2 B | ||
|
Aytu BioScience
AYTU
|
-1.16 | $ 2.64 | - | $ 16.6 M | ||
|
CNS Pharmaceuticals
CNSP
|
-0.035 | $ 2.36 | -3.67 % | $ 902 K | ||
|
CorMedix
CRMD
|
0.0028 | $ 6.57 | 0.46 % | $ 473 K | ||
|
Avenue Therapeutics
ATXI
|
-0.0465 | - | -52.27 % | $ 4.45 M | ||
|
Burford Capital Limited
BUR
|
12.2 | $ 8.24 | 2.36 % | $ 1.33 B | ||
|
Autolus Therapeutics plc
AUTL
|
-1.92 | $ 1.5 | -0.99 % | $ 383 M | ||
|
Athira Pharma
ATHA
|
-0.167 | - | - | $ 269 M | ||
|
CureVac N.V.
CVAC
|
-8.58 | - | - | $ 867 M |